Sec22b is a critical and nonredundant regulator of plasma cell maintenance.
Saved in:
| Title: | Sec22b is a critical and nonredundant regulator of plasma cell maintenance. |
|---|---|
| Authors: | Bonaud A; Université Paris-Cité, Institut de Recherche Saint-Louis, INSERM U1160, F-75010 Paris, France.; CNRS, GDR3697 'Microenvironment of tumor niches,' Micronit, France.; OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Hôpital Saint-Louis, 75010 Paris, France., Gargowitsch L; Université Paris-Saclay, INSERM, Inflammation, Microbiome and Immunosurveillance, 92140 Clamart, France., Gilbert SM; Department of Medicine, University of Cambridge, Cambridge Biomedical Campus, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK., Rajan E; School of Bioscience, University of Sheffield, Sheffield S102TN, UK., Canales-Herrerias P; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, Université de Paris, INSERM UMR1222, F-75015 Paris, France., Stockholm D; PSL Research University, EPHE, 75014 Paris, France.; Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine, CRSA, F-75012 Paris, France., Rahman NF; Dementia Research Institute, University of Cardiff, Cardiff CF24 4HQ, UK., Collins MO; School of Bioscience, University of Sheffield, Sheffield S102TN, UK., Taskiran H; Institute of Clinical Chemistry and Pathobiochemistry, School of Medicine, Technical University of Munich, Munich 81675, Germany.; TranslaTUM, Center for Translational Cancer Research, Technical University of Munich, Munich 81675, Germany.; Max Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg im Breisgau, Germany., Hill DL; Lymphocyte Signalling and Development, Babraham Institute, Cambridge CB22 3AT, UK.; Department of Immunology and Pathology, Monash University, Melbourne, VIC 3004, Australia., Alloatti A; PSL Research University, Institut Curie Research Center, INSERM U932, 75005 Paris, France.; Facultad de Ciencias Médicas, Instituto de Inmunología Clínica y Experimental de Rosario (IDICER)-CONICET/Universidad Nacional de Rosario, S2002LRL Rosario, Argentina., Alouche N; Université Paris-Saclay, INSERM, Inflammation, Microbiome and Immunosurveillance, 92140 Clamart, France., Balor S; METi, Centre de Biologie Intégrative, Université de Toulouse, CNRS, UPS, 31062, Toulouse, France., Soldan V; METi, Centre de Biologie Intégrative, Université de Toulouse, CNRS, UPS, 31062, Toulouse, France., Gillet D; Université Paris-Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé, SIMoS, Gif-sur-Yvette 91191, France., Barbier J; Université Paris-Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé, SIMoS, Gif-sur-Yvette 91191, France., Bachelerie F; Université Paris-Saclay, INSERM, Inflammation, Microbiome and Immunosurveillance, 92140 Clamart, France., Smith KGC; Department of Medicine, University of Cambridge, Cambridge Biomedical Campus, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK.; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre Cambridge Biomedical, University of Cambridge, Cambridge CB2 0AW, UK., Jellusova J; Institute of Clinical Chemistry and Pathobiochemistry, School of Medicine, Technical University of Munich, Munich 81675, Germany.; TranslaTUM, Center for Translational Cancer Research, Technical University of Munich, Munich 81675, Germany., Bruhns P; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, Université de Paris, INSERM UMR1222, F-75015 Paris, France., Amigorena S; PSL Research University, Institut Curie Research Center, INSERM U932, 75005 Paris, France., Balabanian K; Université Paris-Cité, Institut de Recherche Saint-Louis, INSERM U1160, F-75010 Paris, France.; CNRS, GDR3697 'Microenvironment of tumor niches,' Micronit, France.; OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Hôpital Saint-Louis, 75010 Paris, France., Linterman MA; Lymphocyte Signalling and Development, Babraham Institute, Cambridge CB22 3AT, UK., Peden AA; School of Bioscience, University of Sheffield, Sheffield S102TN, UK., Espéli M; Université Paris-Cité, Institut de Recherche Saint-Louis, INSERM U1160, F-75010 Paris, France.; CNRS, GDR3697 'Microenvironment of tumor niches,' Micronit, France.; OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Hôpital Saint-Louis, 75010 Paris, France. |
| Source: | Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2023 Jan 10; Vol. 120 (2), pp. e2213056120. Date of Electronic Publication: 2023 Jan 03. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1091-6490 (Electronic) Linking ISSN: 00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36595686 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Sec22b is a critical and nonredundant regulator of plasma cell maintenance. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Bonaud+A%22">Bonaud A</searchLink>; Université Paris-Cité, Institut de Recherche Saint-Louis, INSERM U1160, F-75010 Paris, France.; CNRS, GDR3697 'Microenvironment of tumor niches,' Micronit, France.; OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Hôpital Saint-Louis, 75010 Paris, France.<br /><searchLink fieldCode="AU" term="%22Gargowitsch+L%22">Gargowitsch L</searchLink>; Université Paris-Saclay, INSERM, Inflammation, Microbiome and Immunosurveillance, 92140 Clamart, France.<br /><searchLink fieldCode="AU" term="%22Gilbert+SM%22">Gilbert SM</searchLink>; Department of Medicine, University of Cambridge, Cambridge Biomedical Campus, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK.<br /><searchLink fieldCode="AU" term="%22Rajan+E%22">Rajan E</searchLink>; School of Bioscience, University of Sheffield, Sheffield S102TN, UK.<br /><searchLink fieldCode="AU" term="%22Canales-Herrerias+P%22">Canales-Herrerias P</searchLink>; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, Université de Paris, INSERM UMR1222, F-75015 Paris, France.<br /><searchLink fieldCode="AU" term="%22Stockholm+D%22">Stockholm D</searchLink>; PSL Research University, EPHE, 75014 Paris, France.; Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine, CRSA, F-75012 Paris, France.<br /><searchLink fieldCode="AU" term="%22Rahman+NF%22">Rahman NF</searchLink>; Dementia Research Institute, University of Cardiff, Cardiff CF24 4HQ, UK.<br /><searchLink fieldCode="AU" term="%22Collins+MO%22">Collins MO</searchLink>; School of Bioscience, University of Sheffield, Sheffield S102TN, UK.<br /><searchLink fieldCode="AU" term="%22Taskiran+H%22">Taskiran H</searchLink>; Institute of Clinical Chemistry and Pathobiochemistry, School of Medicine, Technical University of Munich, Munich 81675, Germany.; TranslaTUM, Center for Translational Cancer Research, Technical University of Munich, Munich 81675, Germany.; Max Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg im Breisgau, Germany.<br /><searchLink fieldCode="AU" term="%22Hill+DL%22">Hill DL</searchLink>; Lymphocyte Signalling and Development, Babraham Institute, Cambridge CB22 3AT, UK.; Department of Immunology and Pathology, Monash University, Melbourne, VIC 3004, Australia.<br /><searchLink fieldCode="AU" term="%22Alloatti+A%22">Alloatti A</searchLink>; PSL Research University, Institut Curie Research Center, INSERM U932, 75005 Paris, France.; Facultad de Ciencias Médicas, Instituto de Inmunología Clínica y Experimental de Rosario (IDICER)-CONICET/Universidad Nacional de Rosario, S2002LRL Rosario, Argentina.<br /><searchLink fieldCode="AU" term="%22Alouche+N%22">Alouche N</searchLink>; Université Paris-Saclay, INSERM, Inflammation, Microbiome and Immunosurveillance, 92140 Clamart, France.<br /><searchLink fieldCode="AU" term="%22Balor+S%22">Balor S</searchLink>; METi, Centre de Biologie Intégrative, Université de Toulouse, CNRS, UPS, 31062, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Soldan+V%22">Soldan V</searchLink>; METi, Centre de Biologie Intégrative, Université de Toulouse, CNRS, UPS, 31062, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Gillet+D%22">Gillet D</searchLink>; Université Paris-Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé, SIMoS, Gif-sur-Yvette 91191, France.<br /><searchLink fieldCode="AU" term="%22Barbier+J%22">Barbier J</searchLink>; Université Paris-Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé, SIMoS, Gif-sur-Yvette 91191, France.<br /><searchLink fieldCode="AU" term="%22Bachelerie+F%22">Bachelerie F</searchLink>; Université Paris-Saclay, INSERM, Inflammation, Microbiome and Immunosurveillance, 92140 Clamart, France.<br /><searchLink fieldCode="AU" term="%22Smith+KGC%22">Smith KGC</searchLink>; Department of Medicine, University of Cambridge, Cambridge Biomedical Campus, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK.; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre Cambridge Biomedical, University of Cambridge, Cambridge CB2 0AW, UK.<br /><searchLink fieldCode="AU" term="%22Jellusova+J%22">Jellusova J</searchLink>; Institute of Clinical Chemistry and Pathobiochemistry, School of Medicine, Technical University of Munich, Munich 81675, Germany.; TranslaTUM, Center for Translational Cancer Research, Technical University of Munich, Munich 81675, Germany.<br /><searchLink fieldCode="AU" term="%22Bruhns+P%22">Bruhns P</searchLink>; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, Université de Paris, INSERM UMR1222, F-75015 Paris, France.<br /><searchLink fieldCode="AU" term="%22Amigorena+S%22">Amigorena S</searchLink>; PSL Research University, Institut Curie Research Center, INSERM U932, 75005 Paris, France.<br /><searchLink fieldCode="AU" term="%22Balabanian+K%22">Balabanian K</searchLink>; Université Paris-Cité, Institut de Recherche Saint-Louis, INSERM U1160, F-75010 Paris, France.; CNRS, GDR3697 'Microenvironment of tumor niches,' Micronit, France.; OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Hôpital Saint-Louis, 75010 Paris, France.<br /><searchLink fieldCode="AU" term="%22Linterman+MA%22">Linterman MA</searchLink>; Lymphocyte Signalling and Development, Babraham Institute, Cambridge CB22 3AT, UK.<br /><searchLink fieldCode="AU" term="%22Peden+AA%22">Peden AA</searchLink>; School of Bioscience, University of Sheffield, Sheffield S102TN, UK.<br /><searchLink fieldCode="AU" term="%22Espéli+M%22">Espéli M</searchLink>; Université Paris-Cité, Institut de Recherche Saint-Louis, INSERM U1160, F-75010 Paris, France.; CNRS, GDR3697 'Microenvironment of tumor niches,' Micronit, France.; OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Hôpital Saint-Louis, 75010 Paris, France. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227505876%22">Proceedings of the National Academy of Sciences of the United States of America</searchLink> [Proc Natl Acad Sci U S A] 2023 Jan 10; Vol. 120 (2), pp. e2213056120. <i>Date of Electronic Publication: </i>2023 Jan 03. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22National+Academy+of+Sciences%22">National Academy of Sciences </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7505876 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1091-6490 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200278424%22">00278424 </searchLink><i>NLM ISO Abbreviation: </i>Proc Natl Acad Sci U S A <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36595686 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1073/pnas.2213056120 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e2213056120 Titles: – TitleFull: Sec22b is a critical and nonredundant regulator of plasma cell maintenance. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Bonaud A – PersonEntity: Name: NameFull: Gargowitsch L – PersonEntity: Name: NameFull: Gilbert SM – PersonEntity: Name: NameFull: Rajan E – PersonEntity: Name: NameFull: Canales-Herrerias P – PersonEntity: Name: NameFull: Stockholm D – PersonEntity: Name: NameFull: Rahman NF – PersonEntity: Name: NameFull: Collins MO – PersonEntity: Name: NameFull: Taskiran H – PersonEntity: Name: NameFull: Hill DL – PersonEntity: Name: NameFull: Alloatti A – PersonEntity: Name: NameFull: Alouche N – PersonEntity: Name: NameFull: Balor S – PersonEntity: Name: NameFull: Soldan V – PersonEntity: Name: NameFull: Gillet D – PersonEntity: Name: NameFull: Barbier J – PersonEntity: Name: NameFull: Bachelerie F – PersonEntity: Name: NameFull: Smith KGC – PersonEntity: Name: NameFull: Jellusova J – PersonEntity: Name: NameFull: Bruhns P – PersonEntity: Name: NameFull: Amigorena S – PersonEntity: Name: NameFull: Balabanian K – PersonEntity: Name: NameFull: Linterman MA – PersonEntity: Name: NameFull: Peden AA – PersonEntity: Name: NameFull: Espéli M IsPartOfRelationships: – BibEntity: Dates: – D: 10 M: 01 Text: 2023 Jan 10 Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1091-6490 Numbering: – Type: volume Value: 120 – Type: issue Value: 2 Titles: – TitleFull: Proceedings of the National Academy of Sciences of the United States of America Type: main |
| ResultId | 1 |